Last updated on January 2017

A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia


Brief description of study

A 12-Week, Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects with Severe Hypertriglyceridemia (INDIGO-1)

Clinical Study Identifier: NCT02944383

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Michael Koren, MD

Jacksonville Center for Clinical Research
Jacksonville, FL United States
  Connect »